  | PIRES PACHECO, M. I., GERARD, D., Mangan, R. J., Chapman, A. R., Hecker, D., Kellis, M., Schulz, M. H., SINKKONEN, L., & SAUTER, T. (10 December 2025). Epigenetic control of metabolic identity across cell types. BMC Genomics, 27 (1), 22. doi:10.1186/s12864-025-12155-y  Peer Reviewed verified by ORBi |
 | Cerella, C., Gajulapalli, S. R., Lorant, A., GERARD, D., Muller, F., Lee, Y., Kim, K. R., Han, B. W., Christov, C., Récher, C., Sarry, J.-E., Dicato, M., & Diederich, M. (2023). ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides. Leukemia. doi:10.1038/s41375-023-02076-8 Peer Reviewed verified by ORBi |
 | Soriano-Baguet, L., Grusdat, M., Kurniawan, H., Benzarti, M., Binsfeld, C., Ewen, A., LONGWORTH, J., Bonetti, L., Guerra, L., Franchina, D. G., Kobayashi, T., Horkova, V., Verschueren, C., Helgueta, S., GERARD, D., More, T. H., Henne, A., Dostert, C., Farinelle, S., ... Brenner, D. (2023). Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions. Cell Reports. doi:10.1016/j.celrep.2023.112153 Peer Reviewed verified by ORBi |
 | Frangez, Z., GERARD, D., He, Z., GAVRIIL, M., Fernández-Marrero, Y., Seyed Jafari, M., Hunger, R., LUCARELLI, P., Yousefi, S., SAUTER, T., SINKKONEN, L., & Simon, H.-U. (2021). ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous Melanoma and Regulated by NRF1. Frontiers in Oncology. doi:10.3389/fonc.2021.721624 Peer Reviewed verified by ORBi |
  | Radogna, F., GERARD, D., Dicato, M., & Diederich, M. (2021). Assessment of Mitochondrial Cell Metabolism by Respiratory Chain Electron Flow Assays. In V. Weissig & M. Edeas (Eds.), Methods in Molecular Biology. New York, United States: Springer. doi:10.1007/978-1-0716-1266-8_9 Peer reviewed |
 | Walter, J., BOLOGNIN, S., Poovathingal, S., MAGNI, S., GERARD, D., ANTONY, P., NICKELS, S. L., Salamanca, L., Berger, E., SMITS, L., GRZYB, K., Perfeito, R., Hoel, F., Qing, X., OHNMACHT, J., Bertacchi, M., Jarazo, J., Ignac, T., Monzel, A., ... SCHWAMBORN, J. C. (2021). The Parkinson’s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1. Cell Reports. doi:10.1016/j.celrep.2021.109864 Peer Reviewed verified by ORBi |
 | Losson, H., Gajulapalli, S. R., Lernoux, M., Lee, J.-Y., Mazumder, A., GERARD, D., Seidel, C., Hahn, H., Christov, C., Dicato, M., Kirsch, G., Han, B. W., Schnekenburger, M., & Diederich, M. (June 2020). The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia. Pharmacological Research, 160. doi:10.1016/j.phrs.2020.105058 Peer Reviewed verified by ORBi |
 | Chateauvieux, S., GAIGNEAUX, A., GERARD, D., Orsini, M., Morceau, F., Orlikova-Boyer, B., Farge, T., Récher, C., Sarry, J.-E., Dicato, M., & Diederich, M. (June 2020). Inflammation regulates long non-coding RNA-PTTG1-1:1 in myeloid leukemia [letter to the editor]. Haematologica, 105 (6), 280-E284. Peer reviewed |
 | Song, S., Lee, J.-Y., Ermolenko, L., Mazumder, A., Ji, S., Ryu, H., KIM, H., Kim, D.-W., LEE, J., Dicato, M., Christov, C., Schnekenburger, M., Cerella, C., GERARD, D., Orlikova-Boyer, B., Al-Mourabit, A., & Diederich, M. (February 2020). Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia. Cell Death and Disease, 11 (2). doi:10.1038/s41419-020-2304-8 Peer reviewed |
 | Grandjenettea, C., Schnekenburger, M., GAIGNEAUX, A., GERARD, D., Christov, C., Mazumder, A., Dicato, M., & Diederich, M. (2020). Human telomerase reverse transcriptase depletion potentiates the growth- T inhibitory activity of imatinib in chronic myeloid leukemia stem cells. Cancer Letters. doi:10.1016/j.canlet.2019.11.017 Peer Reviewed verified by ORBi |
 | Klaus, C., Hansen, J. N., GINOLHAC, A., GERARD, D., Gnanapragassam, V. S., Horstkorte, R., Rossdam, C., Buettner, F. F. R., SAUTER, T., SINKKONEN, L., Neumann, H., & Linnartz-Gerlach, B. (2020). Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice. Neurobiology of Aging. doi:10.1016/j.neurobiolaging.2020.01.008 Peer Reviewed verified by ORBi |
 | Lernoux, M., Schnekenburger, M., Losson, H., Vermeulen, K., Hahn, H., GERARD, D., Lee, J.-Y., Mazumder, A., Ahamed, M., Christov, C., Kim, D.-W., Dicato, M., Bormans, G., Han, B. W., & Diederich, M. (2020). Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. Clinical Epigenetics, 12 (1), 69. doi:10.1186/s13148-020-00839-z Peer Reviewed verified by ORBi |
 | BECKER, J. C., GERARD, D., GINOLHAC, A., SAUTER, T., & SINKKONEN, L. (2019). Identification of genes under dynamic post-transcriptional regulation from time-series epigenomic data. Epigenomics. doi:10.2217/epi-2018-0084 Peer Reviewed verified by ORBi |
 | NICKELS, S., Walter, J., BOLOGNIN, S., GERARD, D., Jäger, C., Qing, X., Tisserand, J., JARAZO, J., Hemmer, K., Harms, A., HALDER, R., Lucarelli, P., Berger, E., ANTONY, P., GLAAB, E., Hankemeier, T., Klein, C., SAUTER, T., SINKKONEN, L., & SCHWAMBORN, J. C. (2019). Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients. Parkinsonism and Related Disorders. doi:10.1016/j.parkreldis.2019.09.018 Peer Reviewed verified by ORBi |
 | GERARD, D., Schmidt, F., GINOLHAC, A., SCHMITZ, M., HALDER, R., Ebert, P., Schulz, M., SAUTER, T., & SINKKONEN, L. (2018). Temporal enhancer profiling of parallel lineages identifies AHR and GLIS1 as regulators of mesenchymal multipotency. Nucleic Acids Research. doi:10.1093/nar/gky1240 Peer Reviewed verified by ORBi |
 | GERARD, D. (2017). APPROACHES FOR IDENTIFICATION OF TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL REGULATORS OF MESENCHYMAL STEM CELL DIFFERENTIATION USING TIME-SERIES EPIGENOMIC DATA [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/33462 |
Dataset: